LENZ Therapeutics, Inc. LENZ

$LENZ FYI per https://fintel.io/ss/us/lenz# short interest ao 4/15 is up to 9,477,902 or now 51% of the float.

$LENZ this is how pathetic Wall Street analysts are. This was from end 4Q:

Raymond James analyst Gary Nachman maintained an Outperform rating and raised the price target from $40 to $50 on Oct. 20, 2025. This analyst has an accuracy rate of 60%.
Piper Sandler analyst Biren Amin maintained an Overweight rating and increased the price target from $51 to $67 on Oct. 10, 2025. This analyst has an accuracy rate of 58%.
Citigroup analyst Yigal Nochomovitz maintained a Buy rating and raised the price target from $49 to $52 on Aug. 1, 2025. This analyst has an accuracy rate of 57%.
HC Wainwright & Co. analyst Matthew Caufield maintained a Buy rating and lifted the price target from $48 to $56 on Aug. 1, 2025. This analyst has an accuracy rate of 72%.

Stock at $9.08 4 months later.

$LENZ the 45000 scrip was their run rate for THIS quarter ending March. The 20000 was for the short quarter ended December.

$LENZ 3 day rule here. Probably get insider buys out a few days. Below cash per share now.

$LENZ all the idiot analysts will go from buy to hold today. Wall St analysts are a joke.

$LENZ down tomorrow but a good entry. Consumer discretionary is bottoming.

$LENZ re consumer discretionary sector bullish percent, as seen here has been falling since our FDA approval, but now back to “tariff day lows”. Oil and rates at upper volatility bands. Good entry

$LENZ last chance.

$LENZ should walk up this next week. Good things.

$LENZ From investor relations:

We will hold our Q4 earnings call the week of March 23rd. As is common practice, we will press release the timing of our earnings call one week ahead.

As well, we held a webcast fireside chat at the Cowen conference last week, and will be holding an additional fireside chat next week at the Leerink conference.